IONS
Ionis Pharmaceuticals Inc
43.50$
-1.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -17.1% | +0.0% | +88.5% | -40.6% | +69.3% | -41.9% | +243.5% | -65.3% | +29.5% | +21.2% | +8.9% | – | |
| – | -1.8% | +0.0% | +93.6% | -74.3% | +257.6% | -60.8% | +176.7% | -43.7% | +242.2% | -62.7% | -8.2% | – | |
| – | -17.4% | +0.0% | +88.4% | -40.0% | +67.8% | -41.6% | +244.2% | -65.5% | +26.3% | +24.7% | +9.1% | – | |
| – | -0.4% | +0.0% | +3.7% | -1.0% | +11.7% | -18.2% | +8.3% | +0.1% | +28.6% | -24.9% | +3.3% | – | |
| – | -24.8% | +0.0% | +23.7% | -5.4% | +43.0% | -13.4% | +18.7% | +6.8% | +34.5% | +15.5% | +0.0% | – | |
| – | -6.5% | +0.0% | +7.6% | -2.0% | +18.5% | -17.0% | +11.2% | +2.1% | +30.3% | -12.1% | +1.9% | – | |
| – | – | – | – | – | – | – | – | -214.6% | – | – | – | – | |
| – | +0.6% | +0.0% | +3.1% | -0.4% | +0.7% | +0.3% | -0.7% | -2.6% | +2.4% | -0.8% | -1.7% | – | |
| – | – | – | – | – | – | – | – | -203.9% | – | – | – | – | |
| – | -98.9% | +0.0% | -14.7% | -5,757.8% | – | – | -117.2% | – | +369.5% | -78.2% | -679.8% | – | |
| – | – | – | – | – | – | – | – | -204.1% | – | – | – | – | |
| – | – | – | – | – | – | – | – | -168.8% | – | -101.5% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.